Description: Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Home Page: www.annovisbio.com
ANVS Technical Analysis
1055 Westlakes Drive
Berwyn,
PA
19312
United States
Phone:
610 727 3913
Officers
| Name | Title |
|---|---|
| Dr. Maria L. Maccecchini Ph.D. | Founder, CEO, Pres & Exec. Director |
| Mr. Henry Hagopian III, M.B.A. | Chief Financial Officer |
| Dr. Cheng Fang Ph.D. | Sr. VP of R&D |
| Ms. Eve M. Damiano M.S., RAC | Sr. VP of Regulatory Operations |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.2862 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2010-02-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |